Dextromethorphan Protects Dopaminergic Neurons against Inflammation-Mediated Degeneration through Inhibition of Microglial Activation

10.1007/978-1-4615-4685-6_10

10.1161/hs1001.096057

10.1073/pnas.87.4.1620

10.1002/(SICI)1522-7146(1996)11:5<217::AID-JBT2>3.0.CO;2-N

10.1016/0006-8993(92)91004-X

10.1016/S0024-3205(97)00132-X

10.1016/0006-8993(95)01189-7

10.1016/S0197-0186(97)00031-4

Castano, 1998, Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system., J Neurochem, 70, 1584, 10.1046/j.1471-4159.1998.70041584.x

10.1016/S0006-8993(99)02267-2

10.1006/brbi.1995.1033

Chao, 1992, Activated microglia mediate cell injury via a nitric oxide mechanism., J Immunol, 149, 128, 10.4049/jimmunol.149.8.2736

10.1016/0006-8993(87)90070-9

Craviso, 1983, High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization., Mol Pharmacol, 23, 619

Craviso, 1983, High-affinity dextromethorphan binding sites in guinea pig brain. II. Competition experiments., Mol Pharmacol, 23, 629

10.1016/0028-3908(94)90045-0

10.1016/0006-8993(94)01294-R

10.1002/glia.440070113

10.1111/j.1749-6632.2002.tb04069.x

10.1016/S0891-5849(98)00293-7

Gayle, 2002, Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β and nitric oxide., Brain Res Dev Brain Res, 133, 27, 10.1016/S0165-3806(01)00315-7

Gao, 2002, Distinct Role for Microglia in Rotenone-induced Degeneration of Dopaminergic Neurons., J Neurosci, 22, 782, 10.1523/JNEUROSCI.22-03-00782.2002

10.1046/j.1471-4159.2002.00928.x

10.1016/0006-8993(88)91011-6

10.1086/302477

Greenamyre, 1999, Mitochondrial dysfunction in Parkinson's disease., Biochem Soc Symp, 66, 85, 10.1042/bss0660085

10.1002/(SICI)1097-4547(19970215)47:4<416::AID-JNR7>3.0.CO;2-H

10.1212/WNL.47.6_Suppl_3.161S

10.1016/S0006-8993(00)02737-2

10.1016/S0165-5728(97)00204-X

Kim, 2000, Regional difference in the susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia., J Neurosci, 20, 6309, 10.1523/JNEUROSCI.20-16-06309.2000

10.1016/0166-2236(96)10049-7

10.1002/syn.890200210

10.1002/mds.10078

Liu, 2000, Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation., J Phar Exp Ther, 293, 607

Liu, 2002, Role of nitric oxide in inflammation-mediated neurodegeneration., Ann NY Acad Sci, 962, 256, 10.1111/j.1749-6632.2002.tb04077.x

10.1124/jpet.102.035048

Liu, 2000, Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide., J Pharmacol Exp Ther, 295, 125

10.1124/jpet.102.035956

10.1016/S0306-4522(00)00033-6

McCord, 1968, The reduction of cytochrome c by milk xanthine oxidase., J Biol Chem, 243, 5753, 10.1016/S0021-9258(18)91929-0

10.1212/WNL.38.8.1285

10.1016/0165-0173(95)00011-9

McGuire, 2002, Tumor necrosis factor α is toxic to embryonic mesencephalic dopamine neurons., Exp Neurol, 169, 219, 10.1006/exnr.2001.7688

10.1016/0006-8993(88)91304-2

10.1016/S0736-5748(99)00096-9

10.1146/annurev.neuro.22.1.123

10.1016/S0009-8981(99)00246-6

10.1016/0304-3940(88)90581-2

10.1046/j.1471-4159.2002.01210.x

10.1016/0024-3205(85)90076-1

Steinberg, 1988, Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits., Stroke, 19, 1112, 10.1161/01.STR.19.9.1112

10.1016/S0022-1759(00)00156-3

10.1016/0165-6147(89)90050-3

Tortella, 1999, Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-d-aspartate antagonist., J Pharmacol Exp Ther, 291, 399

10.1211/0022357991772466

Xie, 2002, Peroxynitrite mediates neurotoxicity of amyloid β-peptide1–42- and lipopolysaccharide-activated microglia., J Neurosci, 22, 3484, 10.1523/JNEUROSCI.22-09-03484.2002